Products
Product Name |
Structure Formula |
CAS / Specification |
Use |
Pregabalin intermediates |
|||
3-isobutylglutaric acid | 75143-89-4 Purity≥99.0% Any single impurity≤0.5% White to off-white crystalline powder |
Intermediate of Pregabalin; | |
3-Isobutylglutaric anhydride | 185815-59-2 Purity≥98.0% Any single impurity≤0.5% Colorless to light yellow liquid?/td> | Intermediate of Pregabalin; | |
3-isobutyl glutaric acid diethyl ester | 294885-98-6 Purity≥97.0% Any single impurity≤0.5% Colorless to yellow transparent liquid?/td> | Intermediate of Pregabalin; | |
(?-3-carbamoymethyl-5-methylhexanoic-acid | 181289-15-6 Purity≥99.0% Any single impurity≤0.5% White crystalline powder |
Intermediate of Pregabalin; | |
(R)-(-)-3-carbamoymethyl-5-methyl-hexanoic acid | 181289-33-8 Purity≥99.0% Any single impurity≤0.5% ee≥99.0% White crystalline powder |
Intermediate of Pregabalin; | |
Lurasidone intermediates | |||
Trans-1,2-Cyclohexanedicarboxylic acid | 2305-32-0 Purity≥98.0% Any single impurity≤0.5% White crystalline powder |
Intermediate of Lurasidone; | |
(1R,2R)-(-)-1,2-Cyclohexanedicarboxylic Acid | 46022-05-3 Purity≥98.0% Any single impurity≤0.5% ee≥99.0% White crystalline powder |
Intermediate of Lurasidone; | |
(1R,2R)-1,2-Cyclohexanedimethanol | 65376-05-8 Purity≥98.0% Any single impurity≤0.5% ee≥99.0% White crystalline powder |
Intermediate of Lurasidone; | |
(1R,2R)-1,2-Bis(methanesulfonyloxymethyl)cyclohexane | 186204-35-3 Purity≥98.0% ee≥99.0% White crystalline powder |
Intermediate of Lurasidone; | |
Midazolam intermediates | |||
2-Amino-5-chloro-2'-fluorobenzophenone?/td> | 784-38-3 Purity≥99.0% Any single impurity≤0.2% Yellow needle crystal |
Intermediate of Midazolam; | |
2-Chloro-N-[4-chloro-2-(2-fluorobenzoyl)phenyl]acetamide | 2836-40-0 Purity≥99.0% Any single impurity≤0.5% Yellow needle crystal |
Intermediate of Midazolam; | |
2-Bromo-N-[4-chloro-2-(2-fluorobenzoyl)phenyl]acetamide | 1584-62-9 Purity≥99.0% Any single impurity≤0.5% Yellow needle crystal |
Intermediate of Midazolan | |
7-Chloro-5-(2-fluoro-phenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | 2886-65-9 Purity≥99.0% Any single impurity≤0.5% White to white crystalline powder |
Intermediate of Midazolam; | |
Bicalutamide intermediates | |||
4-Amino-2-(trifluoromethyl)benzonitrile | 654-70-6 Purity≥99.0% Any single impurity≤0.1% White to white crystalline powder |
Intermediate of Bicalutamide; | |
N-[4-Cyano-3-(trifloromethyl)phenyl]-2-methacrylamide | 90357-53-2 Purity≥99.0% Any single impurity≤0.1% White to white crystalline powder |
Intermediate of Bicalutamide; | |
N-[4-Cyano-3-(trifloromethyl)phenyl]methacrylamide epoxide | 90357-51-0 Purity≥99.0% Any single impurity≤0.1% White to white crystalline powder |
Intermediate of Bicalutamide; | |
N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)thio]-2-hydroxy-2-methylpropionamide | ?0356-78-8 Purity≥99.0% Any single impurity≤0.1% White to white crystalline powder |
Intermediate of Bicalutamide; | |
Enzalutamide | |||
4-Bromo-2-fluoro-N-methylbenzamide | 749927-69-3 Purity≥99.0% Any single impurity≤0.5% White Solid |
Intermediate of Enzalutamide | |
N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine | 1289942-66-0 Purity≥99.0% Any single impurity≤0.5% White Solid |
Intermediate of Enzalutamide | |
N-[3-Fluoro-4-[(methylamino)carbonyl]phenyl]-2-methylalanine methyl ester | 1332524-01-2 Purity≥99.0% Any single impurity≤0.5% White Solid |
Intermediate of Enzalutamide | |
4-Isothiocyanato-2-(trifluoromethyl)benzonitrile | 143782-23-4 Purity≥98.0% Any single impurity≤0.5% Off-White to White Solid |
Intermediate of Enzalutamide | |
Enzalutamide impurity I | 1242137-18-3 Purity≥98.0% Any single impurity≤1.0% Off-White to White Solid |
Impurity of Enzalutamide | |
Enzalutamide impurity II | 1242137-16-1 Purity≥98.0% Any single impurity≤1.0% Off-White to White Solid |
Impurity of Enzalutamide | |
Enzalutamide impurity III | 915087-16-0 Purity≥98.0% Any single impurity≤1.0% Off-White to White Solid |
Impurity of Enzalutamide | |
Enzalutamide impurity IV | 1802242-43-8 Purity≥98.0% Any single impurity≤1.0% Off-White to White Solid |
Impurity of Enzalutamide | |
Enzalutamide impurity V | Purity≥98.0% Any single impurity≤1.0% Off-White to White Solid |
Impurity of Enzalutamide | |
Enzalutamide impurity VI | Purity≥98.0% Any single impurity≤1.0% Off-White to White Solid |
Impurity of Enzalutamide | |
Enzalutamide | 915087-33-1 Purity≥99.5% Any single impurity≤0.1% White Solid |
API | |
Tolvaptan | |||
Tolvaptan | 150683-30-0 Purity≥99.5% Any single impurity≤0.1% White solid |
AVP receptor antagonist; | |
1-(4-Amino-2-methylbenzoyl)-7-chloro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-one | 137977-97-0 Purity≥99.0% Any single impurity≤0.5% Off-white to white solid |
Intermediate of Tolvaptan; | |
7-Chloro-1,2,3,4-tetrahydro-1-(2-methyl-4-nitrobenzoyl)-5H-1-benzazepin-5-one | 137982-91-3 Purity≥99.0% Any single impurity≤0.5% Yellow to light yellow solid |
Intermediate of Tolvaptan; | |
N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide | 137973-76-3 Purity≥99.0% Any single impurity≤0.5% Off-white to white solid |
Intermediate of Tolvaptan; | |
2-Methyl-4-(2-methylbenzoylamino)benzoic acid | 317374-08-6 Purity≥99.0% Any single impurity≤0.5% Off-white to white solid |
Intermediate of Tolvaptan; | |
7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one | 160129-45-3 Purity≥99.0% Any single impurity≤0.1% Yellow to light yellow solid |
Intermediate of Tolvaptan; | |
9-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one | 247237-56-5 Purity≥98.0% Any single impurity≤1.0% Light brown solid |
Impurity of Tolvaptan | |
8-Chloro-1,2,3,4-tetrahydro-benzo[b]azepin-5-one | 116815-03-3 Purity≥98.0% Any single impurity≤1.0% Light brown solid |
Impurity of Tolvaptan | |
7-bromo-1,2,3,4-tetrahydro-benzo[b]azepin-5-one | 3951-89-1 Purity≥98.0% Any single impurity≤1.0% Light brown solid |
Impurity of Tolvaptan | |
Conivaptan hydrochloride intermediates | |||
1,2,3,4-Tetrahydro-benzo[b]azepin-5-one | 1127-74-8 Purity≥98.0% Any single impurity≤1.0% Yellow to light yellow solid |
Intermediate of Conivaptan hydrochloride; | |
1-(Toluene-4-sulfonyl)-1,2,3,4-tetrahydrobenzo[b]azepin-5-one | 24310-36-9 Purity≥99.0% Any single impurity≤0.5% Yellow to light yellow solid |
Intermediate of Conivaptan hydrochloride; | |
4-(2-Phenylbenzamido)benzoic acid | 168626-74-2 Purity≥99.0% Any single impurity≤0.5% Off-white to white solid |
Intermediate of Conivaptan hydrochloride; | |
Vildagliptin intermediates | |||
L-Prolinamide | 7531-52-4 Purity≥97.0% Assay牋 98.0%~102.0% Off-white to white solid |
Intermediate of Vildagliptin | |
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile | 207557-35-5 Purity≥99.0% Any single impurity≤0.5% White solid |
Intermediate of Vildagliptin | |
Adamantane series | |||
1-(5-Bromo-2-methoxy-phenyl)adamantane | 104224-63-7 Purity≥98.0% Any single impurity≤1.0% Off-white solid |
Intermediate of Adapalene | |
Others | |||
3-Ethylbicyclo[3.2.0]hept-3-en-6-one | 1235479-59-0 Purity≥98.0% Any single impurity≤1.0% Colorless liquid |
Intermediate of Mirogabalin | |
2,2,2-Trichloroacetamide | 594-65-0 Purity≥99.0% White cystalline solid |
Intermediate of Eplerenone; | |
3-Propylglutarate | 4165-98-4 Purity≥98.0% Any single impurity≤1.0% Light brown liquid |
Intermediate of Brivaracetam | |
L-Alanine isopropyl ester hydrochloride (H-Ala-OiPr.HCl) |
62062-65-1 Purity≥98.0% Off-white to white solid |
Intermediate of Sofosbuvir | |
4-Bromomethyl-1,2-dihydroquinoline-2-one | 4876-10-2 Purity≥99.0% Any single impurity≤0.5% Off-white to white solid |
Intermediate of Rebamipide | |
4-Bromo-2-fluorobenzoic acid methyl ester | 179232-29-2 Purity≥98.0% Any single impurity≤1.0% White solid |
Intermediate of venetoclax?/td> | |
Benzbromarone | 3562-84-3 Purity≥99.0% Any single impurity≤0.5% White to yellowish solid?/td> | API | |
Benzarone | 1477-19-6 Purity≥98.0% Any single impurity≤0.5% Brown solid |
API | |
Entacapone | 130929-57-6 Purity≥99.5% Any single impurity≤0.1% yellow solid |
API |